Using a web platform for equitable distribution of COVID-19 monoclonal antibodies: a case study in resource allocation

While medical countermeasures in COVID-19 have largely focused on vaccinations, monoclonal antibodies (mAbs) were early outpatient treatment options for COVID-positive patients. In Minnesota, a centralized access platform was developed to offer access to mAbs that linked over 31,000 patients to care...

Full description

Bibliographic Details
Main Authors: Jonathon P. Leider, Sarah Lim, Debra DeBruin, Alexandra T. Waterman, Barbara Smith, Umesh Ghimire, Haley Huhtala, Zachary Zirnhelt, Ruth Lynfield, John L. Hick
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1226935/full
_version_ 1797426221624066048
author Jonathon P. Leider
Sarah Lim
Debra DeBruin
Alexandra T. Waterman
Barbara Smith
Umesh Ghimire
Haley Huhtala
Zachary Zirnhelt
Ruth Lynfield
John L. Hick
author_facet Jonathon P. Leider
Sarah Lim
Debra DeBruin
Alexandra T. Waterman
Barbara Smith
Umesh Ghimire
Haley Huhtala
Zachary Zirnhelt
Ruth Lynfield
John L. Hick
author_sort Jonathon P. Leider
collection DOAJ
description While medical countermeasures in COVID-19 have largely focused on vaccinations, monoclonal antibodies (mAbs) were early outpatient treatment options for COVID-positive patients. In Minnesota, a centralized access platform was developed to offer access to mAbs that linked over 31,000 patients to care during its operation. The website allowed patients, their representative, or providers to screen the patient for mAbs against Emergency Use Authorization (EUA) criteria and connect them with a treatment site if provisionally eligible. A validated clinical risk scoring system was used to prioritize patients during times of scarcity. Both an ethics and a clinical subject matter expert group advised the Minnesota Department of Health on equitable approaches to distribution across a range of situations as the pandemic evolved. This case study outlines the implementation of this online platform and clinical outcomes of its users. We assess the impact of referral for mAbs on hospitalizations and death during a period of scarcity, finding in particular that vaccination conferred a substantially larger protection against hospitalization than a referral for mAbs, but among unvaccinated users that did not get a referral, chances of hospitalization increased by 4.1 percentage points.
first_indexed 2024-03-09T08:27:09Z
format Article
id doaj.art-f27bdbc8041340f0977317dda2c32aba
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-03-09T08:27:09Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-f27bdbc8041340f0977317dda2c32aba2023-12-02T21:07:19ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-11-011110.3389/fpubh.2023.12269351226935Using a web platform for equitable distribution of COVID-19 monoclonal antibodies: a case study in resource allocationJonathon P. Leider0Sarah Lim1Debra DeBruin2Alexandra T. Waterman3Barbara Smith4Umesh Ghimire5Haley Huhtala6Zachary Zirnhelt7Ruth Lynfield8John L. Hick9Center for Public Health Systems, Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, United StatesMinnesota Department of Health, Saint Paul, MN, United StatesCenter for Bioethics, University of Minnesota, Minneapolis, MN, United StatesMinnesota Department of Health, Saint Paul, MN, United StatesHealth Sciences Technology, University of Minnesota, Minneapolis, MN, United StatesCenter for Public Health Systems, Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, United StatesHealth Sciences Technology, University of Minnesota, Minneapolis, MN, United StatesMinnesota Department of Health, Saint Paul, MN, United StatesMinnesota Department of Health, Saint Paul, MN, United StatesHennepin Healthcare, Minneapolis, MN, United StatesWhile medical countermeasures in COVID-19 have largely focused on vaccinations, monoclonal antibodies (mAbs) were early outpatient treatment options for COVID-positive patients. In Minnesota, a centralized access platform was developed to offer access to mAbs that linked over 31,000 patients to care during its operation. The website allowed patients, their representative, or providers to screen the patient for mAbs against Emergency Use Authorization (EUA) criteria and connect them with a treatment site if provisionally eligible. A validated clinical risk scoring system was used to prioritize patients during times of scarcity. Both an ethics and a clinical subject matter expert group advised the Minnesota Department of Health on equitable approaches to distribution across a range of situations as the pandemic evolved. This case study outlines the implementation of this online platform and clinical outcomes of its users. We assess the impact of referral for mAbs on hospitalizations and death during a period of scarcity, finding in particular that vaccination conferred a substantially larger protection against hospitalization than a referral for mAbs, but among unvaccinated users that did not get a referral, chances of hospitalization increased by 4.1 percentage points.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1226935/fullpublic health preparednessCOVID-19 responsescarce resource allocationcase studymonoclonal antibodyequitable allocation of resources
spellingShingle Jonathon P. Leider
Sarah Lim
Debra DeBruin
Alexandra T. Waterman
Barbara Smith
Umesh Ghimire
Haley Huhtala
Zachary Zirnhelt
Ruth Lynfield
John L. Hick
Using a web platform for equitable distribution of COVID-19 monoclonal antibodies: a case study in resource allocation
Frontiers in Public Health
public health preparedness
COVID-19 response
scarce resource allocation
case study
monoclonal antibody
equitable allocation of resources
title Using a web platform for equitable distribution of COVID-19 monoclonal antibodies: a case study in resource allocation
title_full Using a web platform for equitable distribution of COVID-19 monoclonal antibodies: a case study in resource allocation
title_fullStr Using a web platform for equitable distribution of COVID-19 monoclonal antibodies: a case study in resource allocation
title_full_unstemmed Using a web platform for equitable distribution of COVID-19 monoclonal antibodies: a case study in resource allocation
title_short Using a web platform for equitable distribution of COVID-19 monoclonal antibodies: a case study in resource allocation
title_sort using a web platform for equitable distribution of covid 19 monoclonal antibodies a case study in resource allocation
topic public health preparedness
COVID-19 response
scarce resource allocation
case study
monoclonal antibody
equitable allocation of resources
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1226935/full
work_keys_str_mv AT jonathonpleider usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT sarahlim usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT debradebruin usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT alexandratwaterman usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT barbarasmith usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT umeshghimire usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT haleyhuhtala usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT zacharyzirnhelt usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT ruthlynfield usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation
AT johnlhick usingawebplatformforequitabledistributionofcovid19monoclonalantibodiesacasestudyinresourceallocation